Advertisement

Vaginal preparation with povidone-iodine or chlorhexidine before hysterectomy: a propensity score matched analysis

Published:August 30, 2021DOI:https://doi.org/10.1016/j.ajog.2021.08.035

      Background

      Antiseptic vaginal preparation is recommended before gynecologic surgery; however, there is a lack of data regarding the effectiveness of different agents.

      Objective

      To compare rates of postoperative infectious complications and hospital utilization with preoperative vaginal preparation using povidone-iodine or chlorhexidine before hysterectomy.

      Study Design

      This was a retrospective analysis of patients who underwent hysterectomy for gynecologic indications at 70 hospitals in a statewide surgical collaborative between January 2017 and December 2019. The primary outcome was postoperative infectious complications (including urinary tract infection, surgical site infections involving superficial, deep, or organ space tissues, or cellulitis) within 30 days of surgery. To adjust for confounding, propensity score matching, 1:1 without replacement and with a caliper of.005 was performed to create cohorts that had vaginal preparation with either povidone-iodine or chlorhexidine and did not differ in observable characteristics. We compared the rates of infectious morbidity and hospital utilization (emergency department visits, readmission, reoperation) in the matched cohorts.

      Results

      In the statewide collaborative, there were 18,184 patients who received povidone-iodine and 3018 who received chlorhexidine. After propensity score matching of 2935 pairs, the povidone-iodine and chlorhexidine groups did not differ in demographics, comorbidities, choice of preoperative antibiotics, benign vs malignant surgical indication, and surgical approach. Povidone-iodine was associated with a lower rate of infectious morbidity (3.0% vs 4.3%; P=.01), urinary tract infection (1.1% vs 1.7%; P=.03) and emergency department visits (7.9% vs 9.7%; P=.01) than with chlorhexidine. There were nonsignificant trends of lower rates of surgical site infection (2.0% vs 2.7%; P=.07) and reoperation (1.6% vs 2.1%; P=.18).

      Conclusion

      This propensity score matched analysis provides evidence that povidone-iodine is preferable to chlorhexidine for vaginal preparation before hysterectomy because of lower rates of infectious morbidity and fewer emergency department visits. However, the absolute differences in infectious morbidity rates were approximately 1%, and in the event of an iodine allergy, chlorhexidine appears to be a reasonable alternative.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • ACOG Practice Bulletin No
        195: prevention of infection after gynecologic procedures.
        Obstet Gynecol. 2018; 131: e172-e189
        • Berríos-Torres S.I.
        • Umscheid C.A.
        • Bratzler D.W.
        • et al.
        Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017.
        JAMA Surg. 2017; 152: 784-791
        • Stone R.
        • Carey E.
        • Fader A.N.
        • et al.
        Enhanced recovery and surgical optimization protocol for minimally invasive gynecologic surgery: an AAGL white paper.
        J Minim Invasive Gynecol. 2021; 28: 179-203
        • Vorherr H.
        • Vorherr U.F.
        • Mehta P.
        • Ulrich J.A.
        • Messer R.H.
        Antimicrobial effect of chlorhexidine and povidone-iodine on vaginal bacteria.
        J Infect. 1984; 8: 195-199
        • Culligan P.J.
        • Kubik K.
        • Murphy M.
        • Blackwell L.
        • Snyder J.
        A randomized trial that compared povidone iodine and chlorhexidine as antiseptics for vaginal hysterectomy.
        Am J Obstet Gynecol. 2005; 192: 422-425
        • Hill A.M.
        • Pauls R.N.
        • Basil J.B.
        • Crisp C.C.
        Chlorhexidine versus iodine vaginal preparation prior to hysterectomy; a randomized controlled trial.
        Obstet Gynecol. 2020; 135: 20S
        • Schwartz M.A.
        • Schoenbrun R.
        • Hua P.
        • et al.
        Use of vaginal chlorhexidine antisepsis prior to hysterectomy to reduce surgical site infection.
        Gynecol Oncol. 2019; 154: 193-194
        • von Elm E.
        • Altman D.G.
        • Egger M.
        • et al.
        The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
        Lancet. 2007; 370: 1453-1457
        • Morgan D.M.
        • Swenson C.W.
        • Streifel K.M.
        • et al.
        Surgical site infection following hysterectomy: adjusted rankings in a regional collaborative.
        Am J Obstet Gynecol. 2016; 214: 259.e1-259.e8
        • Erekson E.A.
        • Yip S.O.
        • Martin D.K.
        • Ciarleglio M.M.
        • Connell K.A.
        • Fried T.R.
        Major postoperative complications after benign gynecologic surgery: a clinical prediction tool.
        Female Pelvic Med Reconstr Surg. 2012; 18: 274-280
        • Center for Disease Control and Prevention
        Surgical site infection (SSI). 2010.
        (Available at:) (Accessed January 15, 2021)
      1. Specifications Manual for Joint Commission National Quality Core Measures. 2010. Available at: https://manual.jointcommission.org/releases/archive/TJC2010B/ProphylacticAntibioticRegimenSelectionForSurgery.html. Accessed September 29, 2021.

        • Uppal S.
        • Harris J.
        • Al-Niaimi A.
        • et al.
        Prophylactic antibiotic choice and risk of surgical site infection after hysterectomy.
        Obstet Gynecol. 2016; 127: 321-329
        • Till S.R.
        • Morgan D.M.
        • Bazzi A.A.
        • et al.
        Reducing surgical site infections after hysterectomy: metronidazole plus cefazolin compared with cephalosporin alone.
        Am J Obstet Gynecol. 2017; 217: 187.e1-187.e11
        • Austin P.C.
        An introduction to propensity score methods for reducing the effects of confounding in observational studies.
        Multivariate Behav Res. 2011; 46: 399-424
        • Badia J.M.
        • Casey A.L.
        • Petrosillo N.
        • Hudson P.M.
        • Mitchell S.A.
        • Crosby C.
        Impact of surgical site infection on healthcare costs and patient outcomes: a systematic review in six European countries.
        J Hosp Infect. 2017; 96: 1-15
        • Jeppson P.C.
        • Balgobin S.
        • Rahn D.D.
        • et al.
        Comparison of vaginal hysterectomy techniques and interventions for benign indications: a systematic review.
        Obstet Gynecol. 2017; 129: 877-886
        • Mahnert N.
        • Kamdar N.
        • Lim C.S.
        • et al.
        Risk factors for emergency department visits after hysterectomy for benign disease.
        Obstet Gynecol. 2017; 130: 296-304
        • Al-Niaimi A.
        • Rice L.W.
        • Shitanshu U.
        • et al.
        Safety and tolerability of chlorhexidine gluconate (2%) as a vaginal operative preparation in patients undergoing gynecologic surgery.
        Am J Infect Control. 2016; 44: 996-998
        • Rastogi S.
        • Glaser L.
        • Friedman J.
        • Carter I.V.
        • Milad M.P.
        Tolerance of chlorhexidine gluconate vaginal cleansing solution: a randomized controlled trial.
        J Gynecol Surg. 2020; 36: 13-19
        • Gupta K.
        • Hooton T.M.
        • Naber K.G.
        • et al.
        International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases.
        Clin Infect Dis. 2011; 52: e103-e120
        • Lachiewicz M.P.
        • Moulton L.J.
        • Jaiyeoba O.
        Pelvic surgical site infections in gynecologic surgery.
        Infect Dis Obstet Gynecol. 2015; 2015: 614950
        • Lin L.
        • Song J.
        • Kimber N.
        • et al.
        The role of bacterial vaginosis in infection after major gynecologic surgery.
        Infect Dis Obstet Gynecol. 1999; 7: 169-174
        • Soper D.E.
        • Bump R.C.
        • Hurt W.G.
        Bacterial vaginosis and trichomoniasis vaginitis are risk factors for cuff cellulitis after abdominal hysterectomy.
        Am J Obstet Gynecol. 1990; 163: 1016-1021
        • Eggers M.
        • Koburger-Janssen T.
        • Ward L.S.
        • Newby C.
        • Müller S.
        Bactericidal and virucidal activity of povidone-iodine and chlorhexidine gluconate cleansers in an in vivo hand hygiene clinical simulation study.
        Infect Dis Ther. 2018; 7: 235-247
        • Managutti A.
        • Managutti S.A.
        • Patel J.
        • Puthanakar N.Y.
        Evaluation of post-surgical bacteremia with use of povidone-iodine and chlorhexidine during mandibular third molar surgery.
        J Maxillofac Oral Surg. 2017; 16: 485-490
        • Rahn R.
        • Schneider S.
        • Diehl O.
        • Schäfer V.
        • Shah P.M.
        Preventing post-treatment bacteremia: comparing topical povidone-iodine and chlorhexidine.
        J Am Dent Assoc. 1995; 126: 1145-1149
        • Shubair M.
        • Stanek R.
        • White S.
        • Larsen B.
        Effects of chlorhexidine gluconate douche on normal vaginal flora.
        Gynecol Obstet Invest. 1992; 34: 229-233